| P50 | author | Daniel H Solomon | Q91503755 |
| P2093 | author name string | Katherine P Liao | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| | Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study | Q24793945 |
| | Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases | Q28744267 |
| | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 |
| | Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. | Q33307666 |
| | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 |
| | Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study | Q33694218 |
| | Total cholesterol and LDL levels decrease before rheumatoid arthritis | Q33931317 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Indices of relative weight and obesity | Q34215861 |
| | Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics | Q34233328 |
| | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 |
| | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 |
| | Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis | Q34348857 |
| | Cigarette smoking and rheumatoid arthritis | Q34461468 |
| | Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 |
| | HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis | Q34625202 |
| | Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 |
| | Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 |
| | Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis | Q34726199 |
| | The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo | Q34989826 |
| | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 |
| | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis | Q35638659 |
| | Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures | Q35768215 |
| | The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity | Q35927748 |
| | Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis | Q35954510 |
| | Redefining overweight and obesity in rheumatoid arthritis patients. | Q36013923 |
| | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis | Q36098818 |
| | Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 |
| | Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 |
| | Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls | Q80244009 |
| | The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study | Q81476241 |
| | Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis | Q82847957 |
| | Prevalence of obesity among adults with arthritis --- United States, 2003--2009 | Q83993677 |
| | Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis | Q36204149 |
| | Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women | Q36496352 |
| | Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis | Q36955395 |
| | Association of body fat with C-reactive protein in rheumatoid arthritis. | Q37163594 |
| | Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms | Q37371379 |
| | Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis | Q37401378 |
| | The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37640953 |
| | A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis | Q37728928 |
| | Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study | Q37789100 |
| | Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis | Q37790040 |
| | Tocilizumab for rheumatoid arthritis: a Cochrane systematic review | Q37800760 |
| | Obesity in rheumatoid arthritis | Q37801496 |
| | Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. | Q40258187 |
| | Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis | Q40497949 |
| | Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis | Q41932479 |
| | Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients | Q41933145 |
| | Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 |
| | Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis | Q41951968 |
| | Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis | Q42498499 |
| | Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis | Q43622165 |
| | Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 |
| | The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis | Q44401296 |
| | Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome | Q44865463 |
| | Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis | Q45004056 |
| | Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 |
| | Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis | Q45251969 |
| | Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure | Q45264986 |
| | Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. | Q46111865 |
| | Insulin resistance and impaired beta cell function in rheumatoid arthritis | Q46161578 |
| | Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey. | Q46838483 |
| | Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis | Q46987065 |
| | Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults | Q48007679 |
| | Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. | Q51501693 |
| | Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. | Q51695204 |
| | Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 |
| | Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 |
| | Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy. | Q54176069 |
| | Inflammation associated with obesity: relationship with blood and bone marrow endothelial cells. | Q54562319 |
| | Smoking and risk of rheumatoid arthritis. | Q55066113 |
| | Are Patients With Rheumatoid Arthritis Less Physically Active Than the General Population? | Q57788745 |
| | Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy | Q57819586 |
| | Elevated C-reactive protein levels in overweight and obese adults | Q57830181 |
| | A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure | Q70565061 |
| | The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis | Q73613525 |
| | Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab | Q79170004 |
| | Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis | Q79610823 |
| P433 | issue | 1 | |
| P921 | main subject | circulatory system | Q11068 |
| | rheumatoid arthritis | Q187255 |
| | inflammation | Q101991 |
| P304 | page(s) | 45-52 | |
| P577 | publication date | 2012-09-16 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis | |
| P478 | volume | 52 | |